SUPERNUS PHARMACEUTICALS, INC. Quarterly Debt-to-equity in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Supernus Pharmaceuticals, Inc. quarterly Debt-to-equity history and growth rate from Q3 2012 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 37.4 %, a 44.5% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 37.4 -29.9 -44.5% Sep 30, 2024
Q2 2024 39.3 -42.2 -51.7% Jun 30, 2024
Q1 2024 40.1 -57 -58.7% Mar 31, 2024
Q4 2023 54.1 -43.4 -44.5% Dec 31, 2023
Q3 2023 67.3 -33.9 -33.5% Sep 30, 2023
Q2 2023 81.5 -18.1 -18.2% Jun 30, 2023
Q1 2023 97.1 -2.2 -2.22% Mar 31, 2023
Q4 2022 97.4 -2.32 -2.33% Dec 31, 2022
Q3 2022 101 +2.84 +2.89% Sep 30, 2022
Q2 2022 99.6 -3.99 -3.85% Jun 30, 2022
Q1 2022 99.3 -9.93 -9.09% Mar 31, 2022
Q4 2021 99.8 -8.62 -7.95% Dec 31, 2021
Q3 2021 98.4 -8.77 -8.19% Sep 30, 2021
Q2 2021 104 +0.12 +0.12% Jun 30, 2021
Q1 2021 109 +11.7 +12% Mar 31, 2021
Q4 2020 108 +6.28 +6.15% Dec 31, 2020
Q3 2020 107 -0.21 -0.2% Sep 30, 2020
Q2 2020 103 -8.99 -8% Jun 30, 2020
Q1 2020 97.5 -19 -16.3% Mar 31, 2020
Q4 2019 102 -19.2 -15.8% Dec 31, 2019
Q3 2019 107 -3.95 -3.55% Sep 30, 2019
Q2 2019 112 +15.2 +15.7% Jun 30, 2019
Q1 2019 116 +36.4 +45.5% Mar 31, 2019
Q4 2018 121 +66.4 +121% Dec 31, 2018
Q3 2018 111 +56.1 +102% Sep 30, 2018
Q2 2018 97.2 +39.4 +68.2% Jun 30, 2018
Q1 2018 80.1 +13.4 +20.1% Mar 31, 2018
Q4 2017 54.9 -21.2 -27.8% Dec 31, 2017
Q3 2017 55.2 -34.1 -38.2% Sep 30, 2017
Q2 2017 57.8 -47.7 -45.2% Jun 30, 2017
Q1 2017 66.7 -43.1 -39.3% Mar 31, 2017
Q4 2016 76.1 -38.6 -33.7% Dec 31, 2016
Q3 2016 89.2 -45 -33.5% Sep 30, 2016
Q2 2016 105 -56.3 -34.8% Jun 30, 2016
Q1 2016 110 -75.6 -40.8% Mar 31, 2016
Q4 2015 115 -112 -49.4% Dec 31, 2015
Q3 2015 134 -90.7 -40.3% Sep 30, 2015
Q2 2015 162 -132 -44.9% Jun 30, 2015
Q1 2015 185 -134 -41.9% Mar 31, 2015
Q4 2014 226 -35.7 -13.6% Dec 31, 2014
Q3 2014 225 +33.5 +17.5% Sep 30, 2014
Q2 2014 294 +160 +120% Jun 30, 2014
Q1 2014 319 +221 +225% Mar 31, 2014
Q4 2013 262 +221 +531% Dec 31, 2013
Q3 2013 191 +142 +286% Sep 30, 2013
Q2 2013 133 Jun 30, 2013
Q1 2013 98.2 Mar 31, 2013
Q4 2012 41.5 Dec 31, 2012
Q3 2012 49.6 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.